|
2 Companies |
|
6 Products |
|
6 Products |
|
14 Mechanisms of Action |
|
1 Trial |
|
105 News |
|
| 123» |
- | NN1213 / Novo Nordisk
Enrollment change, Trial withdrawal: Visceral Artery Aneurysm Embolization by the Penumbra Ruby (clinicaltrials.gov) - Apr 19, 2019
P4, N=0, Withdrawn, Sponsor: Penumbra Inc.
N=60 --> 0 | Not yet recruiting --> Withdrawn
- | paclitaxel / Generic mfg.
Trial completion, Trial primary completion date: FISBAL: Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon (clinicaltrials.gov) - Feb 22, 2019
P3, N=134, Completed, Sponsor: Fundaci
N=60 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Completed | Trial primary completion date: Oct 2017 --> Oct 2018
- | rosuvastatin / Generic mfg.
Trial completion: Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula (clinicaltrials.gov) - Feb 19, 2019
P2, N=60, Completed, Sponsor: National Cheng-Kung University Hospital
Recruiting --> Completed | Trial primary completion date: Oct 2017 --> Oct 2018 Recruiting --> Completed
- | Trial completion, Phase classification, Enrollment change, Trial completion date, Trial primary completion date: Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease (clinicaltrials.gov) - Feb 12, 2019
P=N/A, N=100, Completed, Sponsor: Sokratis Stoumpos
Recruiting --> Completed Recruiting --> Completed | Phase classification: P4 --> PN/A | N=40 --> 100 | Trial completion date: Dec 2018 --> Sep 2018 | Trial primary completion date: Jun 2018 --> Sep 2018
- | NN1213 / Novo Nordisk
Trial completion: Apollo (clinicaltrials.gov) - Jul 26, 2018
P=N/A, N=112, Completed, Sponsor: Medtronic Neurovascular Clinical Affairs
Recruiting --> Completed | Phase classification: P4 --> PN/A | N=40 --> 100 | Trial completion date: Dec 2018 --> Sep 2018 | Trial primary completion date: Jun 2018 --> Sep 2018 Active, not recruiting --> Completed
- | Enrollment change, Trial withdrawal: Continuous Suturing Versus Interrupted Clips for Brachiocephalic AV Fistula Creation (clinicaltrials.gov) - Jul 6, 2018
P=N/A, N=0, Withdrawn, Sponsor: University of South Florida
Active, not recruiting --> Completed N=164 --> 0 | Recruiting --> Withdrawn
- | Trial completion: Neurovascular Non Contrast-Enhanced MR Angiography at 3T (clinicaltrials.gov) - Apr 17, 2018
P=N/A, N=80, Completed, Sponsor: Rennes University Hospital
N=164 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date, Surgery: NIRS Measurement After SCP Block (clinicaltrials.gov) - Apr 12, 2018
P=N/A, N=15, Completed, Sponsor: Marienhospital Stuttgart
Recruiting --> Completed Recruiting --> Completed | N=25 --> 15 | Trial completion date: May 2017 --> Jan 2018 | Trial primary completion date: Mar 2017 --> Sep 2017
- | Enrollment change, Trial withdrawal: Regional Anesthesia for Arteriovenous Fistula (clinicaltrials.gov) - Mar 21, 2018
P=N/A, N=0, Withdrawn, Sponsor: McMaster University
Recruiting --> Completed | N=25 --> 15 | Trial completion date: May 2017 --> Jan 2018 | Trial primary completion date: Mar 2017 --> Sep 2017 N=105 --> 0 | Suspended --> Withdrawn
- ||| Trial completion: dAVF: ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae (clinicaltrials.gov) - Mar 9, 2018
P=N/A, N=110, Completed, Sponsor: Medtronic Neurovascular Clinical Affairs
N=105 --> 0 | Suspended --> Withdrawn Active, not recruiting --> Completed
- | Phase classification: Apollo (clinicaltrials.gov) - Mar 9, 2018
P=N/A, N=112, Active, not recruiting, Sponsor: Medtronic Neurovascular Clinical Affairs
Active, not recruiting --> Completed Phase classification: P4 --> P=N/A
- | Trial completion, Trial primary completion date: Arteriovenous Fistula Tissue Bank for Pre- and Post-Fistula Placement Specimens (clinicaltrials.gov) - Feb 5, 2018
P=N/A, N=43, Completed, Sponsor: University of Nebraska
Phase classification: P4 --> P=N/A Recruiting --> Completed | Trial primary completion date: Nov 2011 --> Nov 2012
- | Trial initiation date: Continuous Suturing Versus Interrupted Clips for Brachiocephalic AV Fistula Creation (clinicaltrials.gov) - Oct 26, 2017
P=N/A, N=164, Recruiting, Sponsor: University of South Florida
Recruiting --> Completed | Trial primary completion date: Nov 2011 --> Nov 2012 Initiation date: Feb 2017 --> Dec 2017
- | paclitaxel / Generic mfg.
Trial primary completion date: FISBAL: Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon (clinicaltrials.gov) - Sep 21, 2017
P3, N=134, Recruiting, Sponsor: Fundaci
Initiation date: Feb 2017 --> Dec 2017 Trial primary completion date: Mar 2017 --> Oct 2017
- | ropivacaine / Generic mfg.
Trial completion, Trial primary completion date, Surgery: A Randomised Trial Comparing Supraclavicular Block vs Supraclavicular and Pecs II Block in Arteriovenous Grafting (clinicaltrials.gov) - Jul 19, 2017
P=N/A, N=36, Completed, Sponsor: Changi General Hospital
Trial primary completion date: Mar 2017 --> Oct 2017 Recruiting --> Completed | Trial primary completion date: Jul 2017 --> Dec 2016
- | NN1213 / Novo Nordisk
Trial completion: Evaluation and Treatment of Patients Spinal Blood Vessel Abnormalities (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=120, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting --> Completed | Trial primary completion date: Jul 2017 --> Dec 2016 Recruiting --> Completed
- | Trial primary completion date: METTRO: Improving Arteriovenous Fistula Patency (clinicaltrials.gov) - Jun 20, 2017
P=N/A, N=212, Completed, Sponsor: Hospital Infanta Sofia
Recruiting --> Completed Trial primary completion date: Dec 2013 --> Sep 2015
- | nitroglycerin / Generic mfg.
Trial termination: Effects of Exercise and Improved Nitric Oxide Bioavailability on Arteriovenous Fistula Maturation (clinicaltrials.gov) - Apr 11, 2017
P=N/A, N=11, Terminated, Sponsor: Duke University
Trial primary completion date: Dec 2013 --> Sep 2015 Completed --> Terminated; Lack of enrollment
- | nitroglycerin / Generic mfg.
Trial completion: Effects of Exercise and Improved Nitric Oxide Bioavailability on Arteriovenous Fistula Maturation (clinicaltrials.gov) - Apr 7, 2017
P=N/A, N=11, Completed, Sponsor: Duke University
Completed --> Terminated; Lack of enrollment Active, not recruiting --> Completed
- ||| Enrollment closed, Enrollment change: Apollo (clinicaltrials.gov) - Mar 10, 2017
P4, N=112, Active, not recruiting, Sponsor: Medtronic Neurovascular Clinical Affairs
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=161 --> 112
- | Enrollment open: Continuous Suturing Versus Interrupted Clips for Brachiocephalic AV Fistula Creation (clinicaltrials.gov) - Feb 19, 2017
P=N/A, N=164, Recruiting, Sponsor: University of South Florida
Recruiting --> Active, not recruiting | N=161 --> 112 Not yet recruiting --> Recruiting
- New trial, Surgery: NIRS Measurement After SCP Block (clinicaltrials.gov) - Feb 7, 2017
P=N/A, N=25, Recruiting, Sponsor: Marienhospital Stuttgart
- Trial completion, Enrollment change, Surgery: RAD0408: A Phase II Study of Spinal Radiosurgery (clinicaltrials.gov) - Jan 26, 2017
P2, N=44, Completed, Sponsor: University of Alabama at Birmingham
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=36 --> 44
- New trial: Continuous Suturing Versus Interrupted Clips for Brachiocephalic AV Fistula Creation (clinicaltrials.gov) - Jan 18, 2017
P=N/A, N=164, Not yet recruiting, Sponsor: University of South Florida
- nitroglycerin / Generic mfg.
Trial primary completion date: Effects of Exercise and Improved Nitric Oxide Bioavailability on Arteriovenous Fistula Maturation (clinicaltrials.gov) - Jan 12, 2017
P=N/A, N=11, Active, not recruiting, Sponsor: Duke University
Active, not recruiting --> Completed | N=36 --> 44 Trial primary completion date: Dec 2016 --> Apr 2016
- ||| Trial initiation date: Visceral Artery Aneurysm Embolization by the Penumbra Ruby (clinicaltrials.gov) - Dec 27, 2016
P4, N=60, Not yet recruiting, Sponsor: Penumbra Inc.
Trial primary completion date: Dec 2016 --> Apr 2016 Initiation date: Sep 2016 --> Jun 2017
- New P4 trial: Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease (clinicaltrials.gov) - Dec 19, 2016
P4, N=40, Recruiting, Sponsor: Sokratis Stoumpos
- || Trial primary completion date: dAVF: ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae (clinicaltrials.gov) - Oct 28, 2016
P=N/A, N=110, Active, not recruiting, Sponsor: Medtronic Neurovascular Clinical Affairs
Initiation date: Sep 2016 --> Jun 2017 Trial primary completion date: Nov 2015 --> Jan 2020
- ||| Trial initiation date, Trial primary completion date: Visceral Artery Aneurysm Embolization by the Penumbra Ruby (clinicaltrials.gov) - Sep 28, 2016
P4, N=60, Not yet recruiting, Sponsor: Penumbra Inc.
Trial primary completion date: Nov 2015 --> Jan 2020 Initiation date: Sep 2015 --> Sep 2016 | Trial primary completion date: Sep 2016 --> Sep 2018
- rosuvastatin / Generic mfg.
Trial primary completion date: Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula (clinicaltrials.gov) - Sep 27, 2016
P2, N=80, Recruiting, Sponsor: National Cheng-Kung University Hospital
Initiation date: Sep 2015 --> Sep 2016 | Trial primary completion date: Sep 2016 --> Sep 2018 Trial primary completion date: Dec 2016 --> Dec 2018
- Trial primary completion date: Regional Anesthesia for Arteriovenous Fistula (clinicaltrials.gov) - Sep 16, 2016
P=N/A, N=105, Suspended, Sponsor: McMaster University
Trial primary completion date: Dec 2016 --> Dec 2018 Trial primary completion date: Jun 2016 --> Dec 2017
- nitroglycerin / Generic mfg.
Enrollment closed, Enrollment change: Effects of Exercise and Improved Nitric Oxide Bioavailability on Arteriovenous Fistula Maturation (clinicaltrials.gov) - Jul 28, 2016
P=N/A, N=11, Active, not recruiting, Sponsor: Duke University
Trial primary completion date: Jun 2016 --> Dec 2017 Recruiting --> Active, not recruiting | N=80 --> 11
- ropivacaine / Generic mfg.
Trial primary completion date, Surgery: A Randomised Trial Comparing Supraclavicular Block vs Supraclavicular and Pecs II Block in Arteriovenous Grafting (clinicaltrials.gov) - Jul 27, 2016
P=N/A, N=36, Recruiting, Sponsor: Changi General Hospital
Recruiting --> Active, not recruiting | N=80 --> 11 Trial primary completion date: Jan 2017 --> Jul 2017
- New trial: Coronal Mode Ultrasound Guided Hemodialysis Cannulation: Comparison With Standard Cannulation Technique (clinicaltrials.gov) - Jun 28, 2016
P=N/A, N=10, Completed, Sponsor: Henry Ford Health System
- Trial completion, Enrollment change: Hippocampal Radiation Exposure and Memory (clinicaltrials.gov) - Jun 23, 2016
P=N/A, N=1, Completed, Sponsor: University Health Network, Toronto
Trial primary completion date: Jan 2017 --> Jul 2017 Recruiting --> Completed | N=30 --> 1
- | New P2 trial: PRO-CNS: Proton Radiotherapy for Primary Central Nervous System Tumours in Adults (clinicaltrials.gov) - Jun 13, 2016
P2, N=500, Recruiting, Sponsor: Uppsala University
- Trial primary completion date: PREST: Cutting Balloon Versus Non-cutting Balloon for the Treatment of Venous Stenosis in the Fistulas of Hemodialyzed Patients (clinicaltrials.gov) - Jun 5, 2016
P=N/A, N=42, Terminated, Sponsor: Centre Hospitalier Universitaire de N?mes
Recruiting --> Completed | N=30 --> 1 Trial primary completion date: May 2016 --> Dec 2015
- New trial: The Relationship Between the Flow of Arteriovenous Fistula and Cardiac Function in Haemodialysis Patients (clinicaltrials.gov) - Apr 26, 2016
P=N/A, N=100, Completed, Sponsor: Sun Yat-sen University
- New trial: Maximizing Native Arteriovenous Fistulae Rates. (clinicaltrials.gov) - Mar 10, 2016
P=N/A, N=136, Completed, Sponsor: Medifil AE
- Trial completion, Enrollment change: Hemodialysis Vascular Access Imaging Study (clinicaltrials.gov) - Feb 24, 2016
P=N/A, N=41, Completed, Sponsor: Renal Research Institute
Trial primary completion date: May 2016 --> Dec 2015 Recruiting --> Completed | N=15 --> 41
- | paclitaxel / Generic mfg.
Enrollment open: FISBAL: Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon (clinicaltrials.gov) - Feb 5, 2016
P3, N=134, Recruiting, Sponsor: Fundaci
Recruiting --> Completed | N=15 --> 41 Not yet recruiting --> Recruiting
- Enrollment change, Trial withdrawal: ACCESS: Paclitaxel Coated PTA Balloons for Treatment of Dysfunctional AV Fistulae and Grafts (clinicaltrials.gov) - Feb 2, 2016
P=N/A, N=0, Withdrawn, Sponsor: C. R. Bard
Not yet recruiting --> Recruiting N=90 --> 0 | Terminated --> Withdrawn
- Trial primary completion date, Surgery: RAD0408: A Phase II Study of Spinal Radiosurgery (clinicaltrials.gov) - Jan 17, 2016
P2, N=36, Active, not recruiting, Sponsor: University of Alabama at Birmingham
N=90 --> 0 | Terminated --> Withdrawn Trial primary completion date: Sep 2015 --> Sep 2016
- Trial primary completion date: Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm (clinicaltrials.gov) - Nov 26, 2015
P=N/A, N=5, Terminated, Sponsor: State University of New York - Upstate Medical University
Trial primary completion date: Sep 2015 --> Sep 2016 Trial primary completion date: Nov 2014 --> Mar 2014
- Enrollment change, Trial termination: PREST: Cutting Balloon Versus Non-cutting Balloon for the Treatment of Venous Stenosis in the Fistulas of Hemodialyzed Patients (clinicaltrials.gov) - Nov 10, 2015
P=N/A, N=42, Terminated, Sponsor: Centre Hospitalier Universitaire de N?mes
Trial primary completion date: Nov 2014 --> Mar 2014 N=92 --> 42 | Recruiting --> Terminated; Inclusion curve too slow.
- New trial, Surgery: Protocol for Staged Stereotactic Radiosurgery for Large Arteriovenous Malformations (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=18, Completed, Sponsor: New York University School of Medicine
- Trial primary completion date: Hemodialysis Vascular Access Imaging Study (clinicaltrials.gov) - Oct 1, 2015
P=N/A, N=15, Recruiting, Sponsor: Renal Research Institute
N=92 --> 42 | Recruiting --> Terminated; Inclusion curve too slow. Trial primary completion date: Jul 2015 --> Oct 2015
- || paclitaxel / Generic mfg.
New P3 trial: FISBAL: Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon (clinicaltrials.gov) - Oct 1, 2015
P3, N=134, Not yet recruiting, Sponsor: Fundaci
- Trial initiation date, Trial suspension: Regional Anesthesia for Arteriovenous Fistula (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=105, Suspended, Sponsor: McMaster University
Trial primary completion date: Jul 2015 --> Oct 2015 Initiation date: Jan 2015 --> Dec 2015 | Not yet recruiting --> Suspended
- Enrollment change, Trial termination, Trial primary completion date: Clipped Versus Handsewn Arteriovenous Fistula Anastomosis (clinicaltrials.gov) - Sep 8, 2015
P=N/A, N=38, Terminated, Sponsor: Gundersen Lutheran Medical Foundation
Initiation date: Jan 2015 --> Dec 2015 | Not yet recruiting --> Suspended N=300 --> 38 | Enrolling by invitation --> Terminated | Trial primary completion date: Aug 2014 --> Dec 2014; minimal accrual